The present invention relates to systems and methods for performing biological assays.
More specifically, this application relates to automated analyzers and assay protocols for use with reagents.
Biological assays using reagents and automated analyzers can involve several process steps for the user. Some assays, as well as the downstream data analysis that is performed after data acquisition, are more complex than others. Existing detection instrumentation uses complex software with a wide variety of variables and settings for the user to set prior to data acquisition. Furthermore, after data acquisition the user must analyze the data using conventional data analysis tools on their own. Currently, users must collect the raw data and plot the data themselves, which is sometimes done incorrectly or inefficiently. Previous systems collect data used to generate a standard curve and then store that data for use with future or subsequent experimental sample analysis. They also use a single data analysis method that is pre-defined prior to measuring experimental samples. Therefore, standards and experimental samples are analyzed in separate assays, in different operator runs, even on different days.
Software used to operate instrumentation is often complex, providing users with a multitude of variables that must be selected. These other instruments stop short of providing users an analysis of the data, and instead force users to perform these calculations themselves. While many users are comfortable doing these calculations in Microsoft® Excel® and other analysis software programs, it adds additional process steps, time, and sources of error for the user before knowing if the experiment was successful or unsuccessful.
Furthermore, the existing inventions describe analyses with less complex methods and which generally use a single type of analysis (e.g. a dose response curve). This analysis, limited for the user, is intended for a single process or assay type. Moreover, existing systems are specific to a single assay process using stored calibration data.
In some embodiments, the invention provides an analysis system utilizing a reagent for performing a biological assay on a sample. The reagent is associated with a machine-readable label. A scanner reads the machine-readable label and generates a scanner signal in response to reading the machine-readable label. A controller receives the scanner signal and selects a corresponding protocol from a plurality of protocols in response to at least the scanner signal. A memory stores the plurality of protocols for the automation of one or more assays performed on one or more samples. A detector generates a detector signal in response to the assay performed on the one or more samples. The detector signal is received by the controller and processed into a data set. A user input module facilitates user selection of assay protocol parameters. The user input module is in communication with the controller. A data processing module is in communication with the controller. The data processing module receives the data set and processes the data set according to the protocol.
In other embodiments, the invention provides a method of performing a biological assay on a sample. An analysis system including a detector, a scanner, a memory module, and a data processor is provided, along with a reagent including a machine-readable label. The machine readable label is scanned with the scanner and generates a scanner signal in response to reading the machine-readable label. A plurality of protocols for biological assays associated with the reagents is provided on the memory module. A protocol from the plurality of protocols is automatically selected in response to the scanner signal, where the protocol requires the reagent. A characteristic of the sample is detected with the detector. The detector generates a detector signal. A data set is collected from the detector signal. The data set is processed according to the protocol with the data processor.
Other aspects of the invention will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the invention are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways.
Referring to
The luminometer 14 is an easy-to-use, highly sensitive microplate luminometer with a broad dynamic range. The luminometer 14 may be used to perform a wide range of luminescent assays, including, for example, bioluminescent reporter, cell-based, and biochemical assays. Referring to
An optical head 54 (
Referring to
A plurality of assay protocols are stored within the memory module 66, e.g. as firmware. The protocols include the sequence and timing required for the automation of one or more assays. The controller controls operation of the injector syringes and other mechanical aspects of the luminometer according to the assay protocols. The protocols also provide instructions for the collection, formatting and processing of the detector signals into a raw data set. The protocols also provide instructions for the final formatting, analysis, and plotting of the raw data.
The controller 62 is in communication with a user interface 70, a scanner 74, and a data processor 78. The user interface 70, scanner 74, and data processor 78 may be stand-alone components in some embodiments of the invention. In other embodiments, they may be components of portable electronic device 82, such as a laptop computer, tablet computer (e.g., an IPAD), or a smart phone. Communication between the controller 62 and the interface module 70, the scanner module 74, and the data processing module 78 may be by wire or wireless communication. Wireless communication may be over a wireless local area network (e.g. a WIFI network), or a telecommunications network. Alternatively, the portable electronic device 82 or individual user 70, scanner 74 and data processor 78 may be wired to the controller 62 via an ETHERNET hub. In still other embodiments, the user interface 70, scanner 74, and data processor 78 may be integrated into the luminometer 14, such that the analyzer system 10 is a single unitary device.
The user interface 70 is provided for viewing automatically selected assay, data analysis, and data output protocols. In some embodiments, the user interface 70 also provides for manual selection of protocols by the user. The user interface 70 includes a screen from which a user may view and select the protocols from the memory module 66. The screen may be, for example, an LCD or LED display and may include a touchscreen capability. The user interface 70 may be the touchscreen display of a tablet computer, or the combination of a keyboard and display of a laptop computer, or may be implemented using a series of buttons, e.g. adjacent to the screen.
The scanner 74 is provided for automatic selection of reagent protocols. In some embodiments, the scanner 74 includes an optical bar code or matrix code reader. The scanner 74 is provided to read a machine readable media, such as a bar code, matrix code or RFID tag attached to a reagent box, bottle, or kit.
Upon reading a machine-readable label that is associated with a reagent, the scanner 74 generates a scanner signal corresponding to the particular reagent. The scanner signal is communicated to the controller 62. Upon receiving the scanner signal, the controller 62 selects one or more corresponding protocols from the memory 66. The available protocol(s) are then displayed on the user interface 70 and provided to the data processor 78.
The data processor 78 communicates with the controller 62 to receive raw data from the controller 62 to process, analyze and plot the data according to the protocol. The processed data, including plots and statistical analysis, may be displayed on the user interface 70, and/or may be displayed on a separate display. In some embodiments, the data processor utilizes Microsoft® Excel®, or other spreadsheet software, for data analysis and processing.
The combination of a user interface 70, scanner 74 and data processor 78 allows for the integration of the workflow steps of a) automatically selecting the correct instrument protocol based on reagent kit machine-readable label, b) data acquisition and then c) automatic data analysis for the user. The user may initiate the protocol by scanning the machine-readable label from the reagent kit box, utilizing the scanner 74 or by making a manual selection on the user interface 74. The protocol will then guide the user through the setup process to begin data acquisition. Once the user begins the method and collects their data, the raw data from the controller 62 is then automatically analyzed and plotted graphically for the user in a pre-defined manner by the data processor 78. Simplified setup may involve fewer user-input variables or more complex setup may involve additional user-input variables. The pre-analyzed data from the data processor 78 may then be exported with the raw data for the user in a final report, where the user can further manipulate the data as desired.
After scanning the reagent kit, the protocol is initiated automatically. The protocol provides instructions for the user to load the samples and/or standards, and the ability for the user to select the type of standard curve they wish to perform, as well as the number of measurement points that are used to generate the standard curve. Next, the user starts the selected method, and the selected method is performed to generate a raw data collection. The raw data may be expressed, for example, in relative light units (RLUs), relative fluorescent units (RFUs), absorbance, or other characteristics of the sample.
Following raw data collection, the data is automatically plotted for the user so that the user does not have to do this following the data collection. Standards are measured at the same time as the experimental samples. The type of standard curve could be of a variety of types (e.g., linear fit, dose response, quadratic equation, etc.) as well as the number of standard points that are used to generate the standard curve (e.g., 2-12 points).
Then, the experimental samples are calculated based on the standard curve to inform the user if their assay worked and to help them interpret the results. The data processor 78 automatically selects a pre-defined template containing the desired curve fitting calculations and can export the data to a pre-defined location. The data processor 78 calculates average raw data for the section of the template containing standards with known concentration.
The data processor 78 also performs regression analysis using a pre-defined regression model, incorporating the average readings for all standards, and plots the trend line. The data processor 78 calculates regression coefficients, a coefficient of determination R2, a standard deviation SD, and other necessary statistical data. Using calculated regression coefficients, the data processor determines and displays concentration for unknowns in a microplate.
The following non-limiting examples illustrate work flow utilizing particular reagents.
Workflow begins when a user scans the barcode of GloMax® CellTiter-Glo® luminescence test kit with the scanner 74.
The following instructions are displayed on the user input screen of the user interface 70:
Next, the protocol populates instructions on the user interface 70 screen:
The raw data is collected and a linear calculation is applied. An average of plate wells A8, B8, and C8 is taken. These are the background controls. The Average Background from each well (A1 to A7, B1 to B7 and C1 to C7) is subtracted. Next, the background-subtracted triplicate samples from A1,B1,C1; A2,B2,C2; etc. through column 7 are averaged.
Next, a plot is made of the Average RLU minus Background values versus the ATP concentration, and graph labels are added. An R2 value is calculated from the linear fit.
Workflow beings when a user scans a barcode of GloMax® Fluorescence Test Kit with the scanner.
The following prompts appear on the user input display of the user interface 70:
A protocol populates the screen:
Next, the raw data is collected and a linear calculation is applied. First, an average of wells A6, B6, and C6 is taken as background controls. The Average Background is then subtracted from each well (A1 to A5, B1 to B5, and C1 to C5). The background-subtracted triplicate samples from A1,B1,C1; A2,B2,C2; etc. through column 5 are averaged.
Next, a plot is generated of the Average RFU minus Background values vs. the DNA concentration and graph labels are applied. An R2 value, calculated from the linear fit, is also applied.
Workflow begins when a user scans the barcode of GloMax® Absorbance Test Kit with the scanner.
A window is displayed on the screen of the user interface 70, with the following instructions for the user:
A protocol subsequently populates the screen:
The raw data is then collected and a linear calculation of the data is applied. First, an average of A8, B8, and C8 is calculated and used as the background controls. Next, the Average Background is subtracted from each well (A1 to A5, B1 to B7, and C1 to C7). The background-subtracted triplicate samples from A1,B1,C1; A2,B2,C2; etc. through column 7 are averaged.
A plot is made of the Average Absorbance minus Background values versus the protein concentration and an R2 value is calculated from the linear fit.
Workflow begins when a user scans the barcode of a GloMax® Nano-Glo® Luminescence Kit.
A window is displayed on the user interface, with the following instructions for the user:
Next, a protocol populates the screen:
The raw data is then collected and a linear calculation of the data is applied. First, wells A8, B8, and C8 are averaged and used as the background controls. Next, the Average Background is subtracted from each well (A1 to A5, B1 to B7, and C1 to C7). The background subtracted triplicate samples from A1,B1,C1; A2,B2,C2; etc. through column 7 are then averaged.
The average RLU-Background values versus the NanoLuc® luciferase concentration are plotted. Labels are applied to the plot and an R2 value, calculated from the linear fit, is displayed.
Thus, the invention provides, among other things, an analyzer with automated protocol prompting. Various features and advantages of the invention are set forth in the following claims.